{{Rsnum
|rsid=1381392
|Gene=CCDC61
|Chromosome=3
|position=28707823
|Orientation=minus
|GMAF=0.118
|Gene_s=CCDC61
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 63.7 | 31.0 | 5.3
| HCB | 82.5 | 16.8 | 0.7
| JPT | 82.3 | 17.7 | 0.0
| YRI | 100.0 | 0.0 | 0.0
| ASW | 96.5 | 3.5 | 0.0
| CHB | 82.5 | 16.8 | 0.7
| CHD | 79.6 | 16.7 | 3.7
| GIH | 65.3 | 30.7 | 4.0
| LWK | 0.0 | 0.0 | 0.0
| MEX | 82.8 | 13.8 | 3.4
| MKK | 97.4 | 2.6 | 0.0
| TSI | 57.8 | 39.2 | 2.9
| HapMapRevision=28
}}{{PMID Auto
|PMID=24084763
|Title=Germline Variants and Advanced Colorectal Adenomas: Adenoma Prevention with Celecoxib Trial Genomewide Association Study
}}

{{PMID Auto
|PMID=19299336
|Title=Genome-wide association study to identify novel loci associated with therapy-related myeloid leukemia susceptibility.
|OA=1
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | FTDNA2}}
{{on chip | Illumina Human 1M}}